Regulatory Updates
Sep 22, 2026•1 min read
FDA Approves ANDA078039 for Meloxicam Oral Tablets (7.5 mg & 15 mg)
The FDA has granted approval for ANDA078039 submitted by CR DOUBLE CRANE for meloxicam oral tablets in 7.5 mg and 15 mg strengths. Both products are listed as discontinued.
Regulatory Updates
Sep 15, 2026•1 min read
FDA Approves ANDA078102 for Meloxicam Oral Tablets
FDA approved application ANDA078102 submitted by TARO for meloxicam tablets (7.5 mg and 15 mg). Both products are listed with discontinued marketing status.
Regulatory Updates
Aug 31, 2026•1 min read
FDA Approves Labeling for Lupin’s Meloxicam Tablets (ANDA 077944)
The FDA’s database lists ANDA 077944 for meloxicam tablets (7.5 mg and 15 mg) by Lupin Pharmaceuticals, with several labeling submissions approved; the products are currently marked discontinued.